226 related articles for article (PubMed ID: 29982822)
1. Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review.
Pittman N; Rawn SM; Wang M; Masetto A; Beattie KA; Larché M
Rheumatology (Oxford); 2018 Oct; 57(10):1802-1811. PubMed ID: 29982822
[TBL] [Abstract][Full Text] [Related]
2. Small intestinal bacterial overgrowth in systemic sclerosis.
Marie I; Ducrotté P; Denis P; Menard JF; Levesque H
Rheumatology (Oxford); 2009 Oct; 48(10):1314-9. PubMed ID: 19696066
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis.
García-Collinot G; Madrigal-Santillán EO; Martínez-Bencomo MA; Carranza-Muleiro RA; Jara LJ; Vera-Lastra O; Montes-Cortes DH; Medina G; Cruz-Domínguez MP
Dig Dis Sci; 2020 Apr; 65(4):1134-1143. PubMed ID: 31549334
[TBL] [Abstract][Full Text] [Related]
4. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.
Parodi A; Sessarego M; Greco A; Bazzica M; Filaci G; Setti M; Savarino E; Indiveri F; Savarino V; Ghio M
Am J Gastroenterol; 2008 May; 103(5):1257-62. PubMed ID: 18422815
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients.
Sawadpanich K; Soison P; Chunlertrith K; Mairiang P; Sukeepaisarnjaroen W; Sangchan A; Suttichaimongkol T; Foocharoen C
Int J Rheum Dis; 2019 Apr; 22(4):695-699. PubMed ID: 30729669
[TBL] [Abstract][Full Text] [Related]
6. Alternative Treatment Approaches to Small Intestinal Bacterial Overgrowth: A Systematic Review.
Nickles MA; Hasan A; Shakhbazova A; Wright S; Chambers CJ; Sivamani RK
J Altern Complement Med; 2021 Feb; 27(2):108-119. PubMed ID: 33074705
[No Abstract] [Full Text] [Related]
7. Small intestinal bacterial overgrowth in systemic sclerosis: a review of the literature.
Polkowska-Pruszyńska B; Gerkowicz A; Szczepanik-Kułak P; Krasowska D
Arch Dermatol Res; 2019 Jan; 311(1):1-8. PubMed ID: 30382339
[TBL] [Abstract][Full Text] [Related]
8. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.
Ghoshal UC; Shukla R; Ghoshal U
Gut Liver; 2017 Mar; 11(2):196-208. PubMed ID: 28274108
[TBL] [Abstract][Full Text] [Related]
9. The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin.
Furnari M; De Alessandri A; Cresta F; Haupt M; Bassi M; Calvi A; Haupt R; Bodini G; Ahmed I; Bagnasco F; Giannini EG; Casciaro R
J Gastroenterol; 2019 Mar; 54(3):261-270. PubMed ID: 30232597
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis.
Feng X; Li XQ; Jiang Z
Clin Rheumatol; 2021 Aug; 40(8):3039-3051. PubMed ID: 33426631
[TBL] [Abstract][Full Text] [Related]
11. What tests should you use to assess small intestinal bacterial overgrowth in systemic sclerosis?
Braun-Moscovici Y; Braun M; Khanna D; Balbir-Gurman A; Furst DE
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S117-22. PubMed ID: 26339892
[TBL] [Abstract][Full Text] [Related]
12. Effect of probiotics on small intestinal bacterial overgrowth in patients with gastric and colorectal cancer.
Liang S; Xu L; Zhang D; Wu Z
Turk J Gastroenterol; 2016 May; 27(3):227-32. PubMed ID: 27210778
[TBL] [Abstract][Full Text] [Related]
13. Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management.
Rao SSC; Bhagatwala J
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00078. PubMed ID: 31584459
[TBL] [Abstract][Full Text] [Related]
14. How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach.
Rezaie A; Pimentel M; Rao SS
Curr Gastroenterol Rep; 2016 Feb; 18(2):8. PubMed ID: 26780631
[TBL] [Abstract][Full Text] [Related]
15. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.
Lombardo L; Foti M; Ruggia O; Chiecchio A
Clin Gastroenterol Hepatol; 2010 Jun; 8(6):504-8. PubMed ID: 20060064
[TBL] [Abstract][Full Text] [Related]
16. The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease.
Barboza JL; Okun MS; Moshiree B
Expert Opin Pharmacother; 2015; 16(16):2449-64. PubMed ID: 26374094
[TBL] [Abstract][Full Text] [Related]
17. Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation.
Rosania R; Giorgio F; Principi M; Amoruso A; Monno R; Di Leo A; Ierardi E
Curr Clin Pharmacol; 2013 May; 8(2):169-72. PubMed ID: 23244247
[TBL] [Abstract][Full Text] [Related]
18. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.
Ghoshal UC; Srivastava D; Misra A; Ghoshal U
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):281-9. PubMed ID: 26731696
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms.
Tauber M; Avouac J; Benahmed A; Barbot L; Coustet B; Kahan A; Allanore Y
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-82-7. PubMed ID: 25372792
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of small intestinal bacterial overgrowth in the clinical practice.
Gabrielli M; D'Angelo G; Di Rienzo T; Scarpellini E; Ojetti V
Eur Rev Med Pharmacol Sci; 2013; 17 Suppl 2():30-5. PubMed ID: 24443065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
